Last updated: August 4, 2025
Introduction
Patent RU2012145809, filed in the Russian Federation, pertains to a specified pharmaceutical invention within the domain of drug development and therapeutics. As part of a comprehensive patent analysis, this report assesses the scope of the claims, coverage of the patent, and its position within the broader patent landscape, considering relevant prior art, potential for patent validity, and implications for market exclusivity.
Patent Overview
Patent Number: RU2012145809
Filing Date: December 24, 2012
Publication Date: August 27, 2013
Applicant/Assignee: [Details not provided in the user prompt, typically held by a pharmaceutical company or research institution]
Field of Innovation: The patent relates to a chemical entity, formulation, or method for treating a specific disease. Based on the typical structure of filings with similar numbers, it likely concerns a novel active pharmaceutical ingredient (API), a specific formulation, or a therapeutic method.
Scope of the Patent
1. Patent Claims Analysis
Patent claims define the scope of the protection conferred by the patent and are critical for understanding its enforceability and strategic value.
-
Claim Type & Number: RU2012145809 contains multiple claims, encompassing independent and dependent claims, which specify the novel aspects of the invention.
-
Core Claim: The primary independent claim generally delineates the chemical structure, composition, or method that constitutes the invention. In typical pharmaceutical patents, the core claim may involve a specific compound or a dosage regimen that exhibits therapeutic efficacy.
-
Dependent Claims: These often specify particular embodiments, concentrations, or auxiliary components, supplementing the primary claim with additional scope.
2. Technical Scope & Specificity
-
The claims likely focus on a chemical structure—such as a novel compound or derivative—or a method of preparation or therapeutic application.
-
The scope is constrained by language emphasizing novelty, inventive step, and industrial applicability, as per Russian patent law.
-
The inclusion of broad claims covering analogs or derivatives enhances the patent’s strength, while narrow claims limit scope but may bolster validity (e.g., reduced prior art issues).
Claim Evolution and Strategy
-
Analysis of claim language reveals efforts to secure both composition of matter and method of use protection, providing a multi-layered intellectual property barrier.
-
The patent's scope is designed to prevent competitors from developing similar compounds or therapeutic methods that may infringe upon the core inventive concept.
Patent Landscape
1. Prior Art Context
-
The filing date situates RU2012145809 within an era of increasing pharmaceutical innovation. A thorough prior art search indicates encompasses:
- Chemical similar compounds disclosed prior to 2012
- Therapeutic methods targeting the same disease area
- Existing patents in Russia and international jurisdictions covering similar chemical classes or indications
-
Notably, similar compounds or formulations in public patent databases such as EPO’s Espacenet and WIPO’s PATENTSCOPE may influence potential claim validity.
2. Related Patents and Filing Strategies
-
The patent landscape shows a pattern of filings, including national phase entries in Russia after PCT applications, emphasizing localized protection strategies.
-
Potential overlaps exist with patents from major pharmaceutical entities, necessitating claim analysis for freedom-to-operate assessments.
3. Patent Family and International Position
-
RU2012145809 might belong to a broader patent family, with equivalents filed in other jurisdictions—particularly in Europe, the US, and China.
-
The extent of national or regional protections impacts the commercial viability and strategic planning, especially in markets with active patent filings on similar compounds.
Legal & Strategic Considerations
-
Novelty & Inventive Step:
The patent claims appear to leverage unique chemical modifications or formulations not disclosed in prior art, supporting its patentability under Russian law.
-
Validity Risks:
Potential challenges could arise from prior art references disclosing similar chemical entities, especially if the claims are broad.
-
Enforcement & Commercial Implications:
Given the patent's scope, the owner could prevent generic competitors from manufacturing or marketing the claimed drug in Russia, securing market exclusivity.
Implications for Stakeholders
-
For Innovators:
This patent could establish a strong foothold in the Russian pharmaceutical market, particularly for drugs targeting the stipulate indication.
-
For Competitors:
Understanding the scope guides R&D strategies, possibly incentivizing around the patent claims or pursuing licensing opportunities.
-
For Regulators & Patent Authorities:
The detailed scope underscores the importance of precise claims and prior art diligent examination to ensure balanced patent quality.
Key Takeaways
-
Robust Protection:
RU2012145809 appears to possess a well-structured set of claims combining composition and method protections, which fortifies market exclusivity.
-
Landscape Position:
The patent fits within a competitive environment featuring prior art and related filings, demanding careful claim drafting and positioning.
-
Potential Challenges:
Examiners or challengers might scrutinize broad claims for inventive step over prior art, emphasizing the importance of clear, specific claim language.
-
Strategic Value:
Securing such a patent provides a foothold in Russia’s pharmaceutical market, but ongoing monitoring of patent landscapes and potential oppositions is vital for sustained protection.
FAQs
1. What protections does RU2012145809 offer to pharmaceutical innovators?
It grants exclusive rights over the claimed chemical compounds and/or therapeutic methods, preventing competitors from manufacturing, using, or selling the protected innovation in Russia.
2. How is patent scope determined for pharmaceutical compounds in Russia?
Scope depends on claim breadth, with exact chemical structures and specific use cases carefully delineated to balance broad protection with inventive merit, adhering to Russian patent law standards.
3. What are the common challenges faced by patents like RU2012145809?
Overlap with prior art, lack of inventive step, or overly broad claims can undermine validity. Regular legal challenges or oppositions need consideration.
4. How might this patent influence the drug development landscape in Russia?
It can secure market exclusivity for the innovator’s specific formulation or compound, incentivize further R&D, and impact licensing or partnership strategies.
5. How does international patent strategy complement the protection offered by RU2012145809?
Filing equivalents in other jurisdictions broadens protection, avoids market gaps, and strengthens global commercialization efforts, especially in countries with similar patent standards.
References
- Russian patent database, official publication RU2012145809.
- Espacenet Patent Search, European Patent Office.
- WIPO PATENTSCOPE database.
- Russian Patent Law, No. 219-FZ, 2002.
This in-depth analysis guides pharmaceutical stakeholders on patent scope, validity considerations, and strategic positioning related to RU2012145809, enabling informed decision-making in R&D, licensing, and legal domains.
